Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sennesael

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Kidney International|September 12, 1998
Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patientsM Jadoul, C Garbar, R Vanholder, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1993
Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiencyJ Sennesael, D Verbeelen, S Degré, et al.
Clinical Nephrology|March 30, 2007
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximabK Budde, J L Bosmans, J Sennesael, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 12, 2006
Severe diarrhea in renal transplant patients: results of the DIDACT studyB Maes, K Hadaya, B de Moor, et al.
Kidney International|June 1, 1997
Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem studyM Jadoul, C Garbar, H Noël, et al.
The American Journal of Cardiology|December 22, 1994
Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patientsM Aparicio, M Dratwa, N el Esper, et al.
Transplantation|December 25, 2012
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoringDirk R J Kuypers, Patrick C Peeters, Jacques J Sennesael, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Kidney International|September 12, 1998
Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patientsM Jadoul, C Garbar, R Vanholder, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1993
Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiencyJ Sennesael, D Verbeelen, S Degré, et al.
Clinical Nephrology|March 30, 2007
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximabK Budde, J L Bosmans, J Sennesael, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 12, 2006
Severe diarrhea in renal transplant patients: results of the DIDACT studyB Maes, K Hadaya, B de Moor, et al.
Kidney International|June 1, 1997
Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem studyM Jadoul, C Garbar, H Noël, et al.
The American Journal of Cardiology|December 22, 1994
Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patientsM Aparicio, M Dratwa, N el Esper, et al.
Transplantation|December 25, 2012
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoringDirk R J Kuypers, Patrick C Peeters, Jacques J Sennesael, et al.
Pageof 5